[{"Assets_0_Q3_USD":183155000.0,"CommonStockSharesOutstanding_0_Q3_shares":73703000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-55327000.0,"NetIncomeLoss_1_Q3_USD":-21668000.0,"NetIncomeLoss_3_Q3_USD":-61085000.0,"StockholdersEquity_0_Q3_USD":107613000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":15508000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":25508000.0,"Ticker":"VSTM","CIK":"1526119","name":"VERASTEM, INC.","OfficialName":"Verastem Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"309307156.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]